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Abstract
Objectives: To determine the relationship between body mass index (BMI), homeostasis model assessment 
– insulin resistance (HOMA-IR) and insulinemia.
Methods: This was a prospective cross-sectional observational study of 132 prepubescent schoolchildren 
residents in the municipality of Santo André, Brazil. Children underwent anthropometric assessment, their glycemia 
and insulinemia were measured and their HOMA-IR index calculated.
Results: Seventy-eight of the 132 children (59.1%) were girls and 54 were boys (40.9%), with a mean age 
of 8.7 years and mean BMI of 13.7 kg/m2. A significant positive association was detected between HOMA-IR and 
BMI, insulin and BMI, weight and HOMA and between insulin and weight. It was also found that the higher the BMI, 
the greater the HOMA score.
Conclusions: The results of this study allow for the conclusion that there is a strong association between 
hyperinsulinism and obesity. Measures should be taken to avoid weight gain during childhood and adolescence.
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Introduction
Insulin is a hormone secreted by the pancreas, 
stimulated by amino acids, fatty acids (FA), ketone bodies 
and especially glucose. The secretion process is strongly 
regulated to maintain stable blood glucose levels in both 
fasting and postprandial conditions.1 Insulin also regulates 
the activity of some enzymes involved in FA synthesis: 
it counterbalances the effects of epinephrine, reducing 
the activity of triacylglycerol lipase and consequently the 
hydrolysis of triacylglycerols (TG) (stored in adipose tissue) 
for the release of free FA.2 
Insulin promotes the use of glucose for energy production 
and stimulates storage of glucose excess as fat.2,3 Thus, 
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hyperinsulinism may signal the development of several 
metabolic disorders4 associated with cardiovascular disease 
(CVD).
Insulin resistance (IR) is defined as a state of subnormal 
biological response to serum insulin levels,5,6 and is 
frequently associated with hyperinsulinism in an attempt 
to obtain an adequate physiological response.4,6,7 One of 
the indicators used for IR assessment is the homeostasis 
model assessment – insulin resistance index (HOMA-IR).8 
This index has been widely used because it is a fast, easy 
and low-cost method,6 and it has been recommended 
even for pediatric age groups.8 Moreover, it provides an 
indirect IR measurement6,9 through the assessment of 
endogenous insulin and glycemia in homeostasis and fasting 
conditions. HOMA-IR has been used in studies with large 
populations,6 because it only requires one fasting sample to 
assess glycemia and insulinemia.10 The following equation 
is used to calculate the index: fasting insulinemia (FI, in 
µUI/mL) x fasting glycemia (FG, in mmol/L)/22.511. When 
first described, the HOMA-IR index was adjusted so that 
a 35-year old healthy individual would present a result 
equal to 1.12
The prevalence of obesity in children is an endemic 
problem,1 although some authors have argued that the it 
has already reached epidemic levels.4,13 Estimates have 
suggested that the prevalence of obesity will reach 5% of the 
pediatric population worldwide by 2010.14 A study conducted 
in some Brazilian cities revealed that overweight and obesity 
affect more than 20% of children and adolescents.15 Data 
from the Brazilian National Demographic and Health Survey 
(Pesquisa Nacional de Demografia e Saúde) indicate a 
prevalence of 7% of overweight in children under 5 years 
of age.16
Obesity increases the risk for development of CVD and 
affects the patient’s physical and social functioning and 
quality of life.13 The presence of obesity during childhood 
and adolescence acts as an important risk factor for its 
persistence and for the development of CVD in adult life.4
FI levels are believed to vary significantly during 
childhood and adolescence, even under normal conditions.13 
Cuartero et al.17 have reported the distribution of HOMA-IR 
percentile values for children and adolescents according 
to pubertal stage. In that study, the 90th percentile for 
prepubertal children was 1.67 for boys and 1.94 for girls.
Vasques el al.6 have presented cutoff points for the 
HOMA-IR index in several populations and age groups: for 
Brazilian patients under 18 years of age, the cutoff point 
was 2.39±1.93.
Based on the above, the objective of the present study 
was to determine the relationship between body mass index 
(BMI), HOMA-IR, and insulinemia, in an attempt to prevent 
the development of some diseases related to hyperinsulinism 
and obesity in children.
Methods 
This was an observational cross-sectional study of 132 
prepubescent schoolchildren (66 obese and 66 at healthy 
weights) from a municipal school in the municipality of 
Santo André, SP, Brazil. The study was approved by Human 
Research Ethics Committee at the Faculdade de Medicina 
do ABC (FMABC) in Santo André.
The initial sample selection was based on the nutritional 
status of all children enrolled at the school: 978/1,018 
(96%). Those children who were found to be obese, 146/978 
(15%), were matched for age and sex with healthy children 
from the same classroom and invited to provide samples 
for laboratory tests.
On the basis of the inclusion criteria (on the roll of the 
school being studied; aged under 10 years and 11 months; 
resident of Santo André; free from chronic diseases; and 
with permission granted by parents or guardians) and the 
exclusion criteria (pubertal development; chronic diseases; 
parents’ disagreement; or failure to attend after three 
invitations), a total of 66 obese patients and 66 healthy 
controls were enrolled. 
Anthropometric assessment consisted of taking weight 
and height measurements as directed by the World Health 
Organization. Body mass index was then calculated and 
converted to a z score and children were defined as obese 
if their BMI z score was greater than +2.6,9,16-18
Puberty was staged according to criteria described by 
Marshall & Tanner.19 
Glycemia (mg/dL) and insulinemia (μUI/mL) were 
assayed and the HOMA-IR index calculated. Blood samples 
were collected into dry tubes (to allow coagulation). A total 
of 10 mL of blood was taken from each child.
The samples were transported to the Clinical Analysis 
Laboratory at the FMABC, within a maximum of 3 hours, 
and centrifuged at 2,500 rpm for 10 minutes. Before this 
process, observations were made to ensure that coagulation 
was complete (in order to prevent the appearance of fibrin, 
since it can lead to incorrect measurements).20
The following criteria were used for analytical sample 
selection: hemolyzed samples were not analyzed (hemolysis 
can lead to too low results), nor were samples with bilirubin 
(since it can reduce figures) jaundiced samples, lipemic 
samples or contaminated samples.20 Serum insulin levels 
were assayed using a solid-phase chemiluminescent 
enzyme immunoassay with two incubations (Immulite 
1000, Siemens®), testing 100 μL of serum. Glycemia was 
assayed using the enzymatic glucose-oxidase method 
(Express Plus, Bayer®).
In order to calculate the HOMA-IR index, it is first 
necessary to convert the glycemia results expressed in 
mg/dL into mmol/L, which was done by multiplying them by 
0.0556. The HOMA-IR index could then be calculated using 
the formula FI x FG/22.5.9 The cutoff point of 2, proposed 
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by Cuartero et al.17 for prepubescent children, was used 
for the HOMA-IR analysis.
Statistical analysis employed the chi-square test to 
compare dichotomous and qualitative variables (sex and 
unhealthy HOMA-IR). Continuous variables were compared 
using Student’s t test (age, BMI z score, glycemia, insulin 
and HOMA-IR) and correlations were analyzed using 
Pearson’s coefficient (BMI z score against glycemia, insulin 
and HOMA-IR). Significance was set at α < 5%. However, 
where Pearson’s coefficients were significant to α < 1%, 
this has also been indicated. Calculations were performed 
using SPSS 13.0.
Results
The general characteristics of the obese and healthy 
weight children are given in Table 1. There were more girls 
than boys in both groups (76/132; 59.1%), and median 
age was 8.7±1.1 years. Insulin resistance (HOMA-IR > 2) 
was observed in 24/66 (36.4%) obese children and 7/66 
(10.6%) of those with healthy weight (p < 0.001) (data 
not shown).
Figure 1 illustrates the correlations between the 
anthropometric variables (BMI z score and abdominal 
waist) and the laboratory variables (glycemia, insulin and 
HOMA-IR). Body mass index z score had a statistically 
significant association with waist measurement, both among 
the obese children and among those with healthy weights 
[r obese = 0.72 (p < 0.01) and r healthy weight = 0.59 
(p < 0.01)] (Table 2). In neither group was there a 
statistically significant correlation between BMI z score or 
waist measurement and insulin, glycemia and HOMA-IR.
The analysis of laboratory variables from the group of 
obese children showed that there was a weak correlation 
between insulin and glycemia (r = 0.27; p < 0.05) and a 
strong correlation between insulin and HOMA-IR (r = 0.98; 
p < 0.01). In the healthy-weight group there was only 
a correlation between insulin and HOMA-IR (r = 0.98; 
p < 0.01) (Figure 1). 
BMI z score = z score for body mass index; 
HOMA-IR = homeostasis model assessment – insulin resistance.
Figure 1 - Correlations between BMI z score and abdominal waist with insulin, glycemia 
and HOMA-IR in obese and healthy-weight children
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Discussion 
The results of this study indicate that there is a strong 
association between anthropometric indices, the HOMA-IR 
index and insulinemia.
Almeida et al.13 reported differences between the sexes in 
the 11 to 12.9 years and 15 to 17.9 years age groups, both 
for insulinemia and HOMA-IR [calculated using the equation 
FG (mmol/dL) x FI (µUI/mL)/25]. In contrast, neither Pivatto 
et al.18 nor da Silva et al.21 detected significant differences 
between the sexes for HOMA-IR and the first of these studies 
also failed to detect differences in terms of serum insulin 
levels. Both of these studies were with adults.
Ferreira et al.9 indicate that insulin levels were 
significantly different between the sexes, being higher 
among girls [17.8±9.9 µUI/mL, 95% confidence interval 
(95%CI) 13.6-22] than among boys (11.9±5.7 µUI/mL, 
95%CI 9.7-14.1). Insulin resistance figures were higher 
in the female sex (3.8±2.2, 95%CI 2.9-4.8) than for 
males (2.6±1.3, 95%CI 2.1-3.1). In contrast, HOMA-IR 
was elevated in obese children of both sexes. The study 
concluded that obese children had several risk factors for the 
development of cardiovascular disease and that the higher 
the IR, the larger number of risk factors and the greater 
the predisposition to emergence of metabolic syndrome, 
diabetes mellitus type 2 and cardiovascular diseases.
Differences in HOMA-IR were not assessed in this study, 
as they were in the studies cited,9,13,18,21 since our samples 
were from prepubescent children.
According to a study conducted by Almeida et al.,13 
HOMA provides better information for pediatric patients 
because hyperglycemia is rarely observed at this age. It 
therefore appears that there is currently a consensus that 
FI is a reliable parameter for assessing IR in children and 
that no other parameters are needed. The results of our 
study also support this statement since it was observed 
that the Pearson correlation coefficients for the comparison 
between HOMA-IR and BMI (Pearson’s coefficient = 0.326) 
and for the comparison between insulin and BMI (Pearson 
coefficient = 0.321) were approximately equal.
In a study published by Silva et al.,21 correlation coefficients 
suggested a significant association between BMI and IR. The 
findings of this study support their results since there was also 
a significant association between BMI and HOMA-IR.
In children and adolescents, obesity generally precedes 
the appearance of hyperinsulinism,22 which is considered 
an independent risk factor for cardiovascular diseases.4,9 
Variable Obese (n = 66) Healthy weight (n = 66) p
Sex (female/male) 37/29 41/25 0.596*
Age (years) 8.8±0.1 8.6±1.1 0.398†
Body mass index (z score) 2.1±0.3 0.6±1.0 < 0.001†
Abdominal waist (cm) 76.6±8.4 56.5±4.0 < 0.001†
Glycemia (mg/dL) 97.0±8.8 93.6±10.5 0.049†
Insulin (µU/mL) 9.7±11.5 4.9±5.1 0.002†
HOMA-IR 2.4±3.0 1.1±1.7 0.002†
HOMA-IR = homeostasis model assessment – insulin resistance.
* Significance according to chi-square test.
†
 Significance according to Student’s t test.
Table 1 - Characteristics of the study population
   Obese children     Healthy-weight children
 BMI z score Waist Insulin Glycemia HOMA BMI z score Waist Insulin Glycemia HOMA
BMI z score 1 0.72* 0.24 0.20 0.23 1 0.59* -0.03 0.10 -0.01
Waist 0.72* 1 0.14 -0.07 0.13 0.59* 1 0.09 0.00 0.07
Insulin 0.24 0.14 1 0.27† 0.98* -0.03 0.09 1 -0.04 0.98*
Glycemia 0.20 -0.07 0.27† 1 0.32* 0.10 0.00 -0.04 1 0.07
HOMA 0.23 0.130 0.98* 0.32* 1 -0.01 0.09 0.989* 0.07 1
HOMA = homeostasis model assessment; BMI z score = z score for body mass index.
* Significance level according to Pearson’s correlation coefficient: p < 0.01.
†
 Significance level according to Pearson’s correlation coefficient: p < 0.05.
Table 2 - Study variables for obese and healthy-weight children 
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Elevated insulin levels are associated with elevated TG 
levels4 and with their accumulation in liver and muscle 
tissues.22 Data from 2004 indicate that 60% of children 
and adolescents who are overweight have a least one risk 
factor for cardiovascular disease.4
Obese and overweight people are a heterogeneous 
subset with a range of metabolic and phenotypical IR 
expressions. People with the same BMI may have different 
IR and differing metabolic characteristics.22
It is possible that the reason for the positive association 
between BMI and HOMA-IR is the fact that fat in the 
mesenteric and omental regions is particularly sensitive to 
lipolytic stimuli and, in the presence of lypolisis products 
draining via the hepatic portal circulation, leads to IR by 
lipotoxicity. Furthermore, because of its high lipolytic capacity 
and reduced sensitivity to the anti-lipolytic stimulus of 
insulin, visceral fat also tends to release greater quantities 
of free fatty acids into the hepatic portal vein.21 Since male 
pattern obesity (greater deposition of fat in the abdominal 
region) has a strong association with metabolic disorders, 
it is important to investigate body fat distribution and its 
relationship with the etiology of hyperinsulinism.4 
Under normal conditions, insulin performs several 
functions in lipid metabolism regulation. However, the same 
is not observed in obese people because of the frequent 
changes that IR causes to the effects of certain enzymes and 
to lipid metabolism.4 This, in turn, intensifies oxidation of free 
fatty acids in serum, provides substrate for TG synthesis in 
the liver and increases hepatic secretion of very low density 
lipoproteins, rich in TG, into the serum.23
The tragic immediacy of the growing number of people 
affected by obesity/insulin resistance syndrome demands 
urgent public health measures directed at early identification 
and intervention during childhood.8 The results reported 
here allow for the conclusion that hyperinsulinism is strongly 
associated with BMI. Ergo, obese children have greater 
chances of developing hyperinsulinism and so certain 
preventative measures are required to avoid excessive 
weight gain during childhood and adolescence.
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